GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of triple agonist: what the trials say vs what this community says — 28 comments in the full submission. View in context.
1k
c/retatrutide·submitted 2 years ago by u/lurker_for_years

triple agonist: what the trials say vs what this community says

Trial Databranch of 7 comments

Posting this because I searched for it and got nothing useful. Setup: 10mg, week 20, constipation present but not ruining anything. I changed exactly one variable — TRIUMPH — and tracked it for 10 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So I am…

Read the full submission and all 28 comments →

This branch

7 comments, started 2 years ago
u/nabila_bakken11 points·2 years ago

nobody should be giving this to anyone without extensive monitoring

replysharereportpermalink
u/careful_gradient_notes8 points·2 years ago

nobody should be giving this to anyone without extensive monitoring

Disagree on that part. 98.4% and 98.3% on the same vial is normal.

replysharereportpermalink
u/rui_only_ro-15 points·2 years ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/renzo_yildiz1 point·2 years ago

triple agonism is dose escalation, do not generalise

replysharereportpermalink
u/heart_rate_bump1 point·2 years ago

research use only, handling and analysis, not protocols

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.